These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 25223271)

  • 1. Parental acceptance of inactivated polio vaccine in Southeast Nigeria: a qualitative cross-sectional interventional study.
    Tagbo BN; Ughasoro MD; Esangbedo DO
    Vaccine; 2014 Oct; 32(46):6157-62. PubMed ID: 25223271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eradicating polio: how the world's pediatricians can help stop this crippling illness forever.
    Orenstein WA;
    Pediatrics; 2015 Jan; 135(1):196-202. PubMed ID: 25548328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parental opinions regarding poliomyelitis immunizations.
    Epee-Bounya A; Gitterman BA; Moon RY
    Clin Pediatr (Phila); 2001 Aug; 40(8):435-40. PubMed ID: 11516050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost analysis of post-polio certification immunization policies.
    Sangrujee N; Cáceres VM; Cochi SL
    Bull World Health Organ; 2004 Jan; 82(1):9-15. PubMed ID: 15106295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors that are associated with parental acceptance of human papillomavirus vaccines: a randomized intervention study of written information about HPV.
    Dempsey AF; Zimet GD; Davis RL; Koutsky L
    Pediatrics; 2006 May; 117(5):1486-93. PubMed ID: 16651301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parental attitudes toward multiple poliovirus injections following a provider recommendation.
    Kolasa MS; Bisgard KM; Prevots DR; Desai SN; Dibling K
    Public Health Rep; 2001; 116(4):282-8. PubMed ID: 12037256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cost-effectiveness of alternative polio immunization policies in South Africa.
    Griffiths UK; Botham L; Schoub BD
    Vaccine; 2006 Jul; 24(29-30):5670-8. PubMed ID: 16766096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing Inactivated Polio Vaccine Introduction and Utilization in Kano State, Nigeria, April-November 2015.
    Osadebe LU; MacNeil A; Elmousaad H; Davis L; Idris JM; Haladu SA; Adeoye OB; Nguku P; Aliu-Mamudu U; Hassan E; Vertefeuille J; Bloland P
    J Infect Dis; 2017 Jul; 216(suppl_1):S137-S145. PubMed ID: 28838186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parental acceptance of human papillomavirus (HPV) vaccination in Indonesia: a cross-sectional study.
    Jaspers L; Budiningsih S; Wolterbeek R; Henderson FC; Peters AA
    Vaccine; 2011 Oct; 29(44):7785-93. PubMed ID: 21821079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parental knowledge and choice regarding live and inactivated poliovirus vaccines.
    Thoms ML; Bodnar PZ; O'Donovan JC; Gouel EG; Walcher JR; Halsey NA
    Arch Pediatr Adolesc Med; 1997 Aug; 151(8):809-12. PubMed ID: 9265883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Inactivated poliovirus vaccine].
    Shimizu H
    Nihon Rinsho; 2011 Sep; 69(9):1604-8. PubMed ID: 21922761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A developing country perspective on vaccine-associated paralytic poliomyelitis.
    John TJ
    Bull World Health Organ; 2004 Jan; 82(1):53-7; discussion 57-8. PubMed ID: 15106301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Worldwide eradication of poliomyelitis].
    Rasch G; Schreier E; Kiehl W; Kurth R
    Wien Klin Wochenschr; 2001 Oct; 113(20-21):839-45. PubMed ID: 11732120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivated polio vaccine: time to introduce it in India's national immunization schedule.
    Verma R; Khanna P; Chawla S
    Hum Vaccin Immunother; 2012 Jul; 8(7):956-8. PubMed ID: 22699444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anomalous observations on IPV and OPV vaccination.
    John TJ
    Dev Biol (Basel); 2001; 105():197-208. PubMed ID: 11763328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Introduction of inactivated polio vaccine (IPV) into the routine immunization schedule of South Africa.
    Schoub BD
    Vaccine; 2012 Sep; 30 Suppl 3():C35-7. PubMed ID: 22939019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccine coverage and determinants of incomplete vaccination in children aged 12-23 months in Dschang, West Region, Cameroon: a cross-sectional survey during a polio outbreak.
    Russo G; Miglietta A; Pezzotti P; Biguioh RM; Bouting Mayaka G; Sobze MS; Stefanelli P; Vullo V; Rezza G
    BMC Public Health; 2015 Jul; 15():630. PubMed ID: 26156158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strengths and weaknesses of current polio vaccines--a view from industry.
    André FE
    Dev Biol (Basel); 2001; 105():61-6. PubMed ID: 11763338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risks associated with the use of live-attenuated vaccine poliovirus strains and the strategies for control and eradication of paralytic poliomyelitis.
    Pliaka V; Kyriakopoulou Z; Markoulatos P
    Expert Rev Vaccines; 2012 May; 11(5):609-28. PubMed ID: 22827246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. National choices related to inactivated poliovirus vaccine, innovation and the endgame of global polio eradication.
    Thompson KM; Duintjer Tebbens RJ
    Expert Rev Vaccines; 2014 Feb; 13(2):221-34. PubMed ID: 24308581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.